Ro, a direct-to-consumer online pharmacy, reaches $500M valuation

Ro, a direct-to-consumer online pharmacy, reaches $500M valuation
Venture capitalists have valued direct-to-consumer telehealth business Ro at $500 million with an $85 million Series B financing, sources confirm to TechCrunch. The fresh round of funding comes seven months after Ro — widely known for its men’s health brand Roman, a cloud pharmacy for erectile dysfunction — made ... read more
Source- Techcrunch.comPublished on 2019-04-16By Kate Clark
6 days ago
Share this content